 |
 |
 |
|
Complement C1q Tumor necrosis factor-Related Protein 9 (CTRP9) is a fat-derived plasma protein that has salutary effects on glucose metabolism and vascular function.
Citations:
- This kit had been used by Dr. Ma on his research paper.
- Yuexing Yuan et al. "C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically globular domain isoform" Am J Physiol Endocrinol Metab 308: E891–E898, 2015
- Dr. Yunhui Du, Dr.Shihan Zhang, et al. Autoantibodies Against β1‐AR Exaggerated Ventricular Remodeling by Inhibiting CTRP9 Expression. Jornal of the American Heart Association (2019). DOI: 10.1161/JAHA.118.010475 https://www.ahajournals.org/doi/full/10.1161/JAHA.118.010475
- Tea Woo Jung, Hyung Sub Park, et al. CTRP9 Regulates Growth, Differentiation, and Apoptosis in Human Keratinocytes through TGFβ1-p38-Dependent Pathway." Mol. Cells 2017; 40(12): 906-915 http://www.molcells.org/journal/view.html?doi=10.14348/molcells.2017.0097
- Sara F. Ahmed, et al. Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females. PLoS One. 2018; 13(12): e0208038. Published online 2018 Dec 17. doi: 10.1371/journal.pone.0208038
- Jimming Pan, Xinguo Cui. et al. "Predictive value of serum CTRP9 and STIM1 for restenosis after cerebrovascular..." Experimental and Therapeutic Medicine 20.3 (2020): 2617-2622
 
 
|
|
|
 |
|
 |
|
|
|
 |
|
 |
|
Features
Human CTRP9 ELISA KIt Code No.: SK00081-02 Size: 96 T Standard range: 0.975 ~ 125 ng/ml Sensitivity: 0.2 ng/ml Sample Type: serum Sample require: 100 uL per well Intra-CV:4-6% Inter-CV: 4-9% Protocol: PDF
|
|
|
|
|
|
|